Health & Biotech
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 136-odd small cap health stocks, 47 saw their share prices fall, 67 improved and 22 were flat.
>> Scroll down for a table showing the performance of small cap health stocks over the past fortnight
It was a good fortnight for health small caps, but an even better one for marijuana health companies for a change.
Twelve of the 30-odd cannabis stocks made respectable gains over the last fortnight, no mean feat given the sector has been in the doldrums since February 2018.
Of the non-cannabis biotechs that were among the 35 that made double-digit gains, only five had news that may have generated share price movement.
Genetic Technologies (ASX:GTG) came through on its promise to tell investors when it’ll start selling its latest cancer risk test (this quarter, in the US).
Kidney disease researcher Dimerix (ASX:DXB) said an independent Safety Review Committee had unanimously recommended a phase 2a study on Focal Segmental Glomerulosclerosis (FSGS) and a phase 2 trial on diabetic kidney disease goes ahead as planned.
FSGS is a nasty and rare disease that attacks the kidney’s filtering units, causing serious scarring. That leads to permanent kidney damage and kidney failure.
Dimerix’s drug, DMX-200, for FSGS has been granted Orphan Drug Designation by the FDA and EMA, a designation to encourage the development of drugs for rare diseases that qualifies Dimerix for various incentives.
These include seven years (FDA) and 10 years (EMA) of market exclusivity if regulatory approval is received, exemption from certain application fees, and an abbreviated regulatory pathway to approval.
The FSGS study completed recruitment in July 2019, with the last patient dosed in September 2019 following final protocol screening. The study remains on track to complete final patient dosing in June 2019.
The diabetic kidney disease study completed recruitment in September 2019, with the last patient dosed in January 2020. Final patient dosing is scheduled for July 2020.
Last week Immutep (ASX:IMM) made a similar announcement, that it was proceeding with recruitment of an additional 19 patients for the third part of its phase 2 TACTI-002 study for patients with second line head and neck squamous cell carcinoma.
The company noted it was receiving good results from the initial stage of the third part of the study.
Adherium (ASX:ADR) has appointed Jane Lapon as head of global market access and reimbursement, a new role to commercialise existing products.
And Cynata Therapeutics (ASX: CYP), a biotech specialising in cell therapeutics, received $1.9m as an R&D tax refund for 2019-20.
| Code | Name | Price (3pm Jan 8) | % Return (2 Weeks) | % Return (1 Year) | Market cap |
|---|---|---|---|---|---|
| CAN | CANN GROUP LTD | 0.850 | 79 | -59 | $121,058,752 |
| IBX | IMAGION BIOSYSTEMS LTD | 0.029 | 71 | -31 | $14,827,184 |
| TDL | TBG DIAGNOSTICS LTD | 0.030 | 67 | -32 | $6,527,619 |
| GTG | GENETIC TECHNOLOGIES LTD | 0.008 | 60 | 22 | $32,505,074 |
| IDT | IDT AUSTRALIA LTD | 0.170 | 55 | 17 | $40,282,036 |
| CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.150 | 50 | 11 | $13,968,750 |
| BPH | BPH ENERGY LTD | 0.002 | 50 | 50 | $5,012,195 |
| ADO | ANTEOTECH LTD | 0.027 | 46 | 49 | $40,346,300 |
| SVA | SIMAVITA LTD-CDI | 0.032 | 39 | 68 | $13,368,900 |
| ALT | ANALYTICA LTD | 0.004 | 33 | -20 | $14,078,449 |
| EXL | ELIXINOL GLOBAL LTD | 0.680 | 32 | -76 | $93,768,000 |
| AC8 | AUSCANN GROUP HOLDINGS LTD | 0.295 | 31 | -58 | $93,528,968 |
| CGS | COGSTATE LTD | 0.495 | 30 | -14 | $83,286,224 |
| SKN | SKIN ELEMENTS LTD | 0.013 | 30 | -32 | $2,112,030 |
| AGH | ALTHEA GROUP HOLDINGS LTD | 0.440 | 29 | 49 | $102,656,400 |
| RAC | RACE ONCOLOGY LTD | 0.230 | 24 | 177 | $25,103,328 |
| BOT | BOTANIX PHARMACEUTICALS LTD | 0.105 | 22 | 52 | $102,133,296 |
| SDX | SIENNA CANCER DIAGNOSTICS LT | 0.040 | 21 | -33 | $13,760,805 |
| RCE | RECCE PHARMACEUTICALS LTD | 0.375 | 21 | 114 | $50,268,868 |
| SIL | SMILES INCLUSIVE LTD | 0.056 | 19 | -79 | $7,461,758 |
| ESE | ESENSE-LAB LTD-CDI | 0.013 | 18 | -48 | $2,471,000 |
| CPH | CRESO PHARMA LTD | 0.135 | 17 | -75 | $23,505,828 |
| IMM | IMMUTEP LTD | 0.285 | 15 | -16 | $111,614,816 |
| CYP | CYNATA THERAPEUTICS LTD | 1.185 | 14 | -9 | $122,076,512 |
| CYC | CYCLOPHARM LTD | 1.275 | 14 | 27 | $99,753,960 |
| IMU | IMUGENE LTD | 0.033 | 14 | 65 | $146,057,024 |
| LCT | LIVING CELL TECHNOLOGIES LTD | 0.017 | 13 | -67 | $9,714,497 |
| MXC | MGC PHARMACEUTICALS LTD | 0.035 | 13 | -20 | $47,989,296 |
| NC6 | NANOLLOSE LTD | 0.054 | 13 | -46 | $4,050,000 |
| MVP | MEDICAL DEVELOPMENTS INTERNA | 8.830 | 12 | 129 | $579,312,192 |
| DXB | DIMERIX LTD | 0.140 | 12 | 59 | $25,413,740 |
| PAR | PARADIGM BIOPHARMACEUTICALS | 3.100 | 11 | 221 | $610,387,200 |
| ADR | ADHERIUM LTD | 0.031 | 11 | -23 | $5,751,149 |
| NEU | NEUREN PHARMACEUTICALS LTD | 2.600 | 11 | 65 | $268,242,048 |
| GMV | G MEDICAL INNOVATION HOLDING | 0.088 | 10 | -68 | $35,984,396 |
| ZLD | ZELIRA THERAPEUTICS LTD | 0.058 | 9 | -6 | $50,601,708 |
| VLS | VITA LIFE SCIENCES LTD | 0.710 | 9 | -11 | $39,466,952 |
| M7T | MACH7 TECHNOLOGIES LTD | 0.730 | 9 | 265 | $133,358,200 |
| ANR | ANATARA LIFESCIENCES LTD | 0.260 | 8 | -42 | $12,935,547 |
| CDX | CARDIEX LTD | 0.029 | 7 | -3 | $21,843,070 |
| JHL | JAYEX HEALTHCARE LTD | 0.030 | 7 | 36 | $5,178,391 |
| PYC | PYC THERAPEUTICS LTD | 0.061 | 7 | 126 | $178,817,104 |
| CDY | CELLMID LTD | 0.235 | 7 | -13 | $22,700,264 |
| BNO | BIONOMICS LTD | 0.082 | 6 | -34 | $44,664,240 |
| ACW | ACTINOGEN MEDICAL LTD | 0.036 | 6 | -23 | $40,292,328 |
| S66 | STAR COMBO PHARMA LTD | 0.480 | 5 | -13 | $41,537,568 |
| PAB | PATRYS LTD | 0.020 | 5 | -29 | $21,451,806 |
| JHC | JAPARA HEALTHCARE LTD | 1.010 | 5 | -7 | $269,919,808 |
| UCM | USCOM LTD | 0.115 | 5 | -23 | $16,804,200 |
| CAJ | CAPITOL HEALTH LTD | 0.235 | 4 | -7 | $180,573,872 |
| VTI | VISIONEERING TECH-CDI | 0.048 | 4 | -70 | $22,358,488 |
| NXS | NEXT SCIENCE LTD | 1.930 | 4 | $347,516,480 | |
| PNV | POLYNOVO LTD | 2.020 | 4 | 237 | $1,335,397,888 |
| ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.130 | 4 | -76 | $22,517,492 |
| HCT | HOLISTA COLLTECH LTD | 0.082 | 4 | 49 | $19,191,206 |
| OSP | OSPREY MEDICAL INC-CDI | 0.030 | 3 | -74 | $12,953,921 |
| AVH | AVITA MEDICAL LTD | 0.645 | 3 | 486 | $1,365,770,880 |
| PBP | PROBIOTEC LTD | 2.008 | 3 | 34 | $150,118,576 |
| ATX | AMPLIA THERAPEUTICS LTD | 0.070 | 3 | -48 | $3,721,941 |
| PCK | PAINCHEK LTD | 0.185 | 3 | 387 | $191,571,648 |
| PIQ | PROTEOMICS INTERNATIONAL LAB | 0.275 | 2 | -36 | $25,267,240 |
| BIT | BIOTRON LTD | 0.055 | 2 | -61 | $38,606,300 |
| KZA | KAZIA THERAPEUTICS LTD | 0.600 | 2 | 74 | $43,300,004 |
| AHX | APIAM ANIMAL HEALTH LTD | 0.430 | 1 | -10 | $49,830,292 |
| NVL | NATIONAL VETERINARY CARE LTD | 3.650 | 1 | 97 | $245,066,928 |
| OPT | OPTHEA LTD | 2.920 | 1 | 387 | $785,940,672 |
| CMP | COMPUMEDICS LTD | 0.805 | 1 | 124 | $142,616,176 |
| VHT | VOLPARA HEALTH TECHNOLOGIES | 1.800 | 0 | 46 | $392,975,968 |
| ACR | ACRUX LTD | 0.190 | 0 | 0 | $31,686,816 |
| FTT | FACTOR THERAPEUTICS LTD | 0.003 | 0 | 50 | $3,128,507 |
| LBT | LBT INNOVATIONS LTD | 0.165 | 0 | 94 | $38,864,064 |
| RAP | RESAPP HEALTH LTD | 0.255 | 0 | 132 | $177,545,152 |
| BLT | BENITEC BIOPHARMA LTD | 0.036 | 0 | -66 | $11,566,333 |
| MDR | MEDADVISOR LTD | 0.370 | 0 | 60 | $90,998,192 |
| IMC | IMMURON LTD | 0.135 | 0 | -45 | $23,924,484 |
| TD1 | TALI DIGITAL LTD | 0.045 | 0 | 55 | $33,718,736 |
| AVE | AVECHO BIOTECHNOLOGY LTD | 0.004 | 0 | -20 | $6,309,830 |
| PXS | PHARMAXIS LTD | 0.150 | 0 | -44 | $59,200,828 |
| NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.190 | 0 | 46 | $14,893,071 |
| 1AD | ADALTA LTD | 0.110 | 0 | -52 | $18,034,018 |
| NTI | NEUROTECH INTERNATIONAL LTD | 0.016 | 0 | -61 | $2,171,902 |
| LSH | LIFESPOT HEALTH LTD | 0.030 | 0 | -50 | $2,327,060 |
| RGS | REGENEUS LTD | 0.083 | 0 | -51 | $23,059,474 |
| VBS | VECTUS BIOSYSTEMS LTD | 0.590 | 0 | 0 | $13,855,558 |
| GLH | GLOBAL HEALTH LTD | 0.145 | 0 | -14 | $6,104,257 |
| SCU | STEMCELL UNITED LTD | 0.013 | 0 | -41 | $8,340,909 |
| MDC | MEDLAB CLINICAL LTD | 0.300 | 0 | -29 | $69,966,544 |
| MVF | MONASH IVF GROUP LTD | 1.020 | 0 | 10 | $240,501,600 |
| TLX | TELIX PHARMACEUTICALS LTD | 1.600 | -1 | 119 | $405,248,000 |
| RSH | RESPIRI LTD | 0.089 | -1 | -1 | $49,506,972 |
| PGC | PARAGON CARE LTD | 0.425 | -1 | -30 | $143,601,248 |
| BWX | BWX LTD | 4.480 | -2 | 209 | $556,639,488 |
| CTE | CRYOSITE LTD | 0.053 | -2 | 18 | $2,483,557 |
| RHT | RESONANCE HEALTH LTD | 0.240 | -2 | 109 | $102,692,144 |
| AMT | ALLEGRA ORTHOPAEDICS LTD | 0.200 | -2 | 0 | $19,911,810 |
| SOM | SOMNOMED LTD | 2.800 | -2 | 53 | $175,851,664 |
| GSS | GENETIC SIGNATURES LTD | 0.970 | -3 | 20 | $138,055,008 |
| OIL | OPTISCAN IMAGING LTD | 0.037 | -3 | -30 | $17,677,816 |
| SDI | SDI LTD | 0.845 | -3 | 42 | $100,441,376 |
| ONT | 1300 SMILES LTD | 6.110 | -3 | -1 | $144,674,928 |
| OCC | ORTHOCELL LTD | 0.455 | -3 | 203 | $83,881,416 |
| IHL | IMPRESSION HEALTHCARE LTD | 0.060 | -3 | 216 | $42,444,956 |
| MMJ | MMJ GROUP HOLDINGS LTD | 0.145 | -3 | -41 | $32,537,852 |
| MEM | MEMPHASYS LTD | 0.050 | -4 | 69 | $37,698,696 |
| PSQ | PACIFIC SMILES GROUP LTD | 1.715 | -4 | 38 | $260,668,672 |
| HLA | HEALTHIA LTD | 1.095 | -4 | 2 | $69,022,944 |
| RHY | RHYTHM BIOSCIENCES LTD | 0.120 | -4 | -11 | $12,090,000 |
| EHH | EAGLE HEALTH HOLDINGS LTD | 0.120 | -4 | -32 | $40,033,992 |
| DVL | DORSAVI LTD | 0.023 | -4 | -62 | $5,016,167 |
| ANP | ANTISENSE THERAPEUTICS LTD | 0.085 | -4 | 174 | $41,546,748 |
| THC | THC GLOBAL GROUP LTD | 0.360 | -5 | -29 | $50,099,340 |
| ALC | ALCIDION GROUP LTD | 0.175 | -5 | 298 | $173,371,456 |
| PAL | PALLA PHARMA LTD | 1.040 | -5 | -6 | $130,985,896 |
| AZV | AZURE HEALTHCARE LTD | 0.080 | -6 | 26 | $22,735,116 |
| APH | AUSTRALIAN PRIMARY HEMP LTD | 0.160 | -6 | -11 | $11,124,822 |
| OSL | ONCOSIL MEDICAL LTD | 0.160 | -6 | -9 | $100,913,408 |
| ELX | ELLEX MEDICAL LASERS LTD | 0.790 | -6 | 28 | $113,444,896 |
| BD1 | BARD1 LIFE SCIENCES LTD | 0.031 | -6 | 20 | $42,382,736 |
| 1ST | 1ST GROUP LTD | 0.075 | -6 | 168 | $31,846,268 |
| BXN | BIOXYNE LTD | 0.015 | -6 | -50 | $9,602,181 |
| OVN | OVENTUS MEDICAL LTD | 0.495 | -7 | 57 | $64,612,208 |
| NOX | NOXOPHARM LTD | 0.265 | -7 | -38 | $35,033,052 |
| RNO | RHINOMED LTD | 0.195 | -7 | 3 | $32,995,174 |
| IVX | INVION LTD | 0.012 | -8 | -29 | $66,007,276 |
| SUD | SUDA PHARMACEUTICALS LTD | 0.059 | -8 | -62 | $8,393,009 |
| UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.175 | -8 | -20 | $31,053,932 |
| OSX | OSTEOPORE LTD | 0.685 | -8 | $69,342,896 | |
| ICS | ICSGLOBAL LTD | 1.820 | -9 | 108 | $19,299,314 |
| FFC | FARMAFORCE LTD | 0.100 | -9 | -13 | $12,877,098 |
| MX1 | MICRO-X LTD | 0.180 | -10 | -36 | $45,003,684 |
| IPD | IMPEDIMED LTD | 0.155 | -14 | -22 | $79,212,640 |
| PAA | PHARMAUST LTD | 0.090 | -14 | 161 | $27,181,894 |
| PTX | PRESCIENT THERAPEUTICS LTD | 0.056 | -15 | -24 | $22,078,596 |
| MEB | MEDIBIO LTD | 0.009 | -18 | -57 | $8,956,170 |
| ATH | ALTERITY THERAPEUTICS LTD | 0.019 | -27 | -57 | $16,579,664 |
| CAN | CANN GROUP LTD | 0.91 | 101 | -54 | $136,013,072 |
NOW READ: Health might be another overnight success in 2020
News
Health & Biotech
News
Get the latest Stockhead news delivered free to your inbox.
